• Most Popular
  • Most Shared

Bayer gets Japan approval for kidney cancer drug

TOKYO
Mon Jan 28, 2008 7:00am EST
A laboratory researcher in a file photo. German drug maker Bayer AG said on Monday that its drug Nexavar had been approved in Japan for the treatment of kidney cancer. REUTERS/Sebastian Derungs

TOKYO (Reuters) - German drug maker Bayer AG said on Monday that its drug Nexavar had been approved in Japan for the treatment of kidney cancer.

Health

Last week, Japanese health authorities granted priority review status for Nexavar to treat liver cancer.

(Reporting by Edwina Gibbs)



More from Reuters

Photo

Obama blames "systemic failures" for plane attack

KANEOHE, Hawaii (Reuters) - President Barack Obama on Tuesday blamed "human and systemic failures" for allowing a botched Christmas Day attack aboard a Detroit-bound airliner and a U.S. official said the incident was linked to al Qaeda. | Video

A man passes by a logo of the Tokyo Stock Exchange at the bourse in Tokyo December 29, 2009. REUTERS/Yuriko Nakao

Toyko trade gets turbocharged

The "Arrowhead" gives Asia's largest -- and long derided -- bourse a viable electronic trading platform, it hopes.  Full Article 

REUTERS/James Saft

Welcome to the "Teenies"

Shrinking financial sector? Paltry investment returns? Welcome to the the next decade. Don't worry, there's some good news, too.  Commentary